Success Metrics

Clinical Success Rate
84.5%

Based on 60 completed trials

Completion Rate
85%(60/71)
Active Trials
36(24%)
Results Posted
42%(25 trials)
Terminated
11(7%)

Phase Distribution

Ph not_applicable
119
81%
Ph phase_3
4
3%
Ph phase_1
5
3%
Ph phase_4
1
1%
Ph phase_2
14
10%

Phase Distribution

5

Early Stage

14

Mid Stage

5

Late Stage

Phase Distribution143 total trials
Phase 1Safety & dosage
5(3.5%)
Phase 2Efficacy & side effects
14(9.8%)
Phase 3Large-scale testing
4(2.8%)
Phase 4Post-market surveillance
1(0.7%)
N/ANon-phased studies
119(83.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

76.9%

60 of 78 finished

Non-Completion Rate

23.1%

18 ended early

Currently Active

36

trials recruiting

Total Trials

147

all time

Status Distribution
Active(50)
Completed(60)
Terminated(18)
Other(19)

Detailed Status

Completed60
Recruiting30
unknown17
Not yet recruiting13
Terminated11
Withdrawn7

Development Timeline

Analytics

Development Status

Total Trials
147
Active
36
Success Rate
84.5%
Most Advanced
Phase 4

Trials by Phase

Phase 15 (3.5%)
Phase 214 (9.8%)
Phase 34 (2.8%)
Phase 41 (0.7%)
N/A119 (83.2%)

Trials by Status

suspended21%
terminated117%
unknown1712%
active_not_recruiting64%
not_yet_recruiting139%
recruiting3020%
enrolling_by_invitation11%
completed6041%
withdrawn75%

Recent Activity

Clinical Trials (147)

Showing 20 of 147 trialsScroll for more
NCT07569133Not Applicable

Efficacy of Repetitive Transcranial Magnetic Stimulation for Improving Depressive Symptoms in Patients With Parkinson's Disease

Enrolling By Invitation
NCT05864313Not Applicable

Gaze and Gait Training With rTMS

Not Yet Recruiting
NCT07562074Phase 1

Transcranial Magnetic Stimulation for Depression in Multiple Sclerosis

Not Yet Recruiting
NCT06138782Not Applicable

Identifying Networks Underlying Compulsivity in Anorexia Nervosa for Targeting With Neuromodulation

Active Not Recruiting
NCT07559084Not Applicable

Multi-target TMS for Schizophrenia Negative Symptoms

Recruiting
NCT05426967Not Applicable

rTMS for Military TBI-related Depression

Recruiting
NCT05567848Phase 1

Accelerated TMS in Psychosis

Suspended
NCT06951035Not Applicable

Impact of rTMS on BCI Control in Upper Limb Motor Rehabilitation of Patients With Chronic Stroke

Recruiting
NCT05570344Not Applicable

rTMS With and Without Text4Support for the Treatment of Resistant Depression.

Recruiting
NCT07112105Not Applicable

Repetitive Transcranial Magnetic Stimulation Treatment of Stimulant Use Disorder

Not Yet Recruiting
NCT04657432Not Applicable

Brief, High-dose rTMS for Depression

Active Not Recruiting
NCT04655963Not Applicable

Brain Stimulation for Improving Cognition in Chronic Stroke (NEPTUNE)

Active Not Recruiting
NCT05100888Not Applicable

Theta-burst rTMS in Schizophrenia to Ameliorate Negative and Cognitive Symptoms

Completed
NCT06639594Phase 1

Feasibility of Accelerated, Personalized rTMS as an Adjuvant for Impulse Control Disorders: a Pilot Study

Recruiting
NCT04294888Not Applicable

TMS in Preclinical and Prodromal AD: Modulation of Brain Networks and Memory

Terminated
NCT07480408Not Applicable

Neural Mechanisms of the Sensorymotor Circuit in Sensory Phenomena in OCD

Not Yet Recruiting
NCT03217110Not Applicable

Cerebellar Stimulation and Cognitive Control

Recruiting
NCT04824105Not Applicable

Modulating Anxious Coping

Recruiting
NCT07474974Not Applicable

ipRGC as a Potential Biomarker for Predicting Transcranial Magnetic Stimulation Treatment Response in Major Depressive Disorder

Not Yet Recruiting
NCT07454954Not Applicable

The Effect of Blood Flow Restriction Training Combined With Transcranial Magnetic Stimulation on Limb Function in Hemiplegic Patients After Stroke

Not Yet Recruiting

Drug Details

Intervention Type
DEVICE
Total Trials
147